Sort   by:  
 Page size 
MetabolomicsGNPS - azodyrecin biosynthesis study (CeMiSt)
Investigation of azodyrecin biosynthesis through heterologous expression and knockout studies in wild type producer (Streptomyces mirabilis P8-A2). FBMN conducted and preprocessing with MS-DIAL.
ORGANISM(S): Streptomyces Albidoflavus (ncbitaxon:1886) Streptomyces Coelicolor (ncbitaxon:1902) Streptomyces Mirabilis (ncbitaxon:68239) 
2023-08-22 | MSV000092718 | GNPS
UnknownSex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
Not available
S-EPMC10944079 | biostudies-literature
UnknownManagement of Coronary Disease in Patients with Advanced Kidney Disease.
Not available
S-EPMC7274537 | biostudies-literature
UnknownHealth Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
Not available
S-EPMC7255621 | biostudies-literature
UnknownFactors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Not available
S-EPMC11187765 | biostudies-literature
UnknownRelationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Not available
S-EPMC11658795 | biostudies-literature
UnknownInitial Invasive or Conservative Strategy for Stable Coronary Disease.
Not available
S-EPMC7263833 | biostudies-literature
UnknownHealth Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
Not available
S-EPMC12492304 | biostudies-literature
UnknownEvaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
Not available
S-EPMC11919559 | biostudies-literature
UnknownHealth-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
Not available
S-EPMC7261489 | biostudies-literature
Sort   by:  
 Page size